Citigroup’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-45,000
Closed -$358K 5870
2025
Q1
$358K Buy
45,000
+5,100
+13% +$37.3K ﹤0.01% 3855
2024
Q4
$217K Hold
39,900
﹤0.01% 4367
2024
Q3
$288K Sell
39,900
-6,800
-15% -$62.3K ﹤0.01% 4098
2024
Q2
$507K Buy
+46,700
New +$598K ﹤0.01% 3386
2023
Q3
Sell
-20,000
Closed -$940K 5789
2023
Q2
$940K Hold
20,000
﹤0.01% 2890
2023
Q1
$839K Sell
20,000
-48,600
-71% -$2.09M ﹤0.01% 2687
2022
Q4
$2.62M Buy
68,600
+48,600
+243% +$1.86M ﹤0.01% 1846
2022
Q3
$783K Hold
20,000
﹤0.01% 2901
2022
Q2
$646K Sell
20,000
-1,300
-6% -$43.6K ﹤0.01% 3028
2022
Q1
$705K Hold
21,300
﹤0.01% 3264
2021
Q4
$906K Buy
+21,300
New +$892K ﹤0.01% 3358
2021
Q1
Sell
-23,900
Closed -$2.07M 7219
2020
Q4
$2.07M Buy
23,900
+7,500
+46% +$553K ﹤0.01% 2827
2020
Q3
$1M Buy
16,400
+2,600
+19% +$132K ﹤0.01% 3271
2020
Q2
$574K Buy
13,800
+4,700
+52% +$171K ﹤0.01% 4111
2020
Q1
$261K Sell
9,100
-10,600
-54% -$614K ﹤0.01% 4506
2019
Q4
$1.42M Buy
19,700
+8,700
+79% +$1.07M ﹤0.01% 3361
2019
Q3
$1.54M Sell
11,000
-5,500
-33% -$920K ﹤0.01% 3145
2019
Q2
$3.02M Sell
16,500
-15,600
-49% -$2.66M ﹤0.01% 2393
2019
Q1
$5.11M Buy
32,100
+5,000
+18% +$724K ﹤0.01% 1759
2018
Q4
$2.6M Buy
27,100
+6,200
+30% +$710K ﹤0.01% 2429
2018
Q3
$2.95M Sell
20,900
-300
-1% -$46.3K ﹤0.01% 2356
2018
Q2
$3.32M Sell
21,200
-4,900
-19% -$769K ﹤0.01% 2218
2018
Q1
$4.2M Buy
26,100
+7,500
+40% +$1.27M ﹤0.01% 1915
2017
Q4
$3.06M Sell
18,600
-3,400
-15% -$330K ﹤0.01% 2272
2017
Q3
$1.37M Buy
22,000
+18,200
+479% +$1.43M ﹤0.01% 3046
2017
Q2
$303K Buy
3,800
+2,500
+192% +$181K ﹤0.01% 4446
2017
Q1
$92K Sell
1,300
-700
-35% -$41K ﹤0.01% 5269
2016
Q4
$102K Buy
+2,000
New +$94.3K ﹤0.01% 5762

Other funds holding SAGE